FDA Regulated Life Science Industry Specialist in cGMP Documentation Complexity Reduction
NEWS FLASH: Brighton Associates wins major victory with a Judgment and Settlement against former employees. The full Judgment is now available in our DOWNLOADS section or read the briefing in the NEWS section.
Brighton Associates is an international consulting company with consultants working at client locations worldwide making products that fall under the USA Code of Federal Regulations (CFRs) Title 21 sections that cover the current Good Manufacturing Practices (cGMP) for what is called "The Life Science Industry".

Since 1996 Brighton Associates has been recognized as the leader in providing Remediation, Assessment and Complexity Reduction of cGMP documentation systems in the Life Science Industry.
CONSULTING SERVICES INCLUDE (but are not limited to)
THE FOLLOWING AREAS OF EXPERTISE:
REMEDIATION ASSESSMENT and CORRECTIVE ACTIONS
cGMP DOCUMENTATION AUTHORING, REDESIGN and COMPLEXITY REDUCTION
  • Outstanding expertise in Assessing Master Batch Records (MBRs), Device History Records (DHRs), Standard Operating Procedures (SOPs) for compliance to FDA cGMP regulations
     
  • Capability to create original, 1st edition documents for defined processes
     
  • Ability to redesign documents to make them more user (management, production and QA reviewers) friendly and reduce the time to issue the records
QUALITY SYSTEM CREATION, SIMPLIFICATION AND COMPLEXITY REDUCTION
PROJECT MANAGEMENT
SOFTWARE SOLUTIONS FOR THE FDA REGULATED INDUSTRY
Phased Approach for SOP, MBRs and DHRs Project
Brighton Associates redesigns your MBRs/DHRs as a stand project or together with your SOPs. A typical project for a combined SOP and MBR/DHR project will performed in a minimum of four (4) phases:

PHASE I: PROJECT ASSESSMENT REVIEW (2-3 Days)
Brighton Associates, at no cost to the client, will come to your site and discuss your issues and expectations prior to a consulting assignment. Most clients take this time to:
  • give us a tour of their site with a focus on document movement and usage.
  • allow as the opportunity to review some of their documents.
  • discuss FDA audits, findings and responses
  • determine the scope and resource requirements for an Assessment.
PHASE II: UNDERSTAND COMPLEXITY ASSESSMENT
We consider your MBRs or DHRs, (depending on your industry segment), the windows to your processes. Most"Right the First Time" monitoring of performance is focused on the MBRs/DHRs due to the necessity to enter process or product specific information into the MBRs/DHRs.
Since the "How to Do" SOP information is where the bulk of the training effort is being done at most companies, it is advisable to begin an assessment of your SOPs with an assessment of your MBRs/DHRs so that the SOPs ability to be in sync with the MBR/DHR can be reviewed.

PHASE III: CHALLENGE AND CREATE PROOF OF CONCEPT (POC) MODEL DOCUMENTS
Our approach is to take what we have learned during our PAR and PHASE II and re-design a POC of the Filling Section of the MBR. This effort will take into consideration both Orencia and Abilify products.
Simultaneously, BA consultants will be redesigning the 12 documents that comprise the Specific SOPs for Filling Section. The goal of our POC is to demonstrate the capabilities of our methodology to deliver quality MBRs and SOPs that are easy to use, reduce the opportunity for error, reduce the amount of complexity and make them capable of delivering an ROI that will justify your investment. All documents will be delivered in MS Word 2007.


Quality Systems and Remediation Assessments
Quality Systems Image
Brighton Associates has the capability to provide in-depth assessments of a company’s Quality Operations to pinpoint opportunities for complexity reduction to improve regulatory compliance, reduce approval cycle times and improve information flows. These systems include:

  • Specific cGMP Documents (Recipes, MBRs/DHRs, SOPs, Specs)
  • CAPA systems
  • FMEA
  • Raw material testing and release
  • Water processing, testing and release
  • Environmental monitoring and control
  • Pharmaceutical manufacturing, testing and release
The Assessments may include:

  • Manufacturing and processing documentation, QC testing documentation, incident, exception and deviation reporting, applicable operating procedures (SOPs), and the various systems and procedures (manual and automated) used to report, track and monitor incidents that affect product release.
  • Personnel involved in each step of the process to gain an understanding of the issues and the potential for gaps to exist in your current situation.
  • Review the current process to determine how it could be expanded and strengthened to ensure that there is complete visibility of any issues that could affect product release.
  • Prepare process flow charts of the current “As-Is” process for handling of incidents, exceptions and deviations. The charts will highlight any variations from applicable procedures and gaps that could negatively impact product release.
  • Prepare process flow charts of a proposed “Should-Be” process for handling of incidents, exceptions, and deviations and ensuring the all relevant information is available in a reliable, single system.
  • Process mapping of your SOPs, through the use of our proprietary software "Spider Webbing", to capture the full current state of your SOPs to understand complexity and process links.
  • Identify where actions can be taken and provide recommendations to improve performance in terms of:
  • improved information availability and reliability, elimination of parallel systems for incident reporting and tracking, consolidation of procedures, etc.


Replace current picture with <<3692578>>
ISO
Standard Operating Procedure Image
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id laborumx.